Massachusetts Healthcare Journal: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Massachusetts Healthcare Journal.

Press releases published on May 19, 2026

UltraSight™ Appoints Rick Geoffrion as Chairman of the Board
SynDevRx to Present AMELIA™-1 Data at ASCO 2026 Showing Improved PI3K/AKT Class Inhibitor Responses in Breast Cancer
Thrive Buildings Partners with CPower to Bring Safe, Scalable Demand Management to Critical Environments
Skineez® Reinvents Compression With Electrolyte-Infused Recovery Socks
SlimTide Claims Evaluated: The Baking Soda Water Shot Gelatin Trick for Losing Weight Naturally by Slim Tide
Monopar Announces Publication of Phase 2 Study Demonstrating ALXN1840 Significantly Improves Copper Balance in Patients with Wilson Disease
Aura Biosciences Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
Journey Medical Corporation to Participate in A.G.P.’s Annual Virtual Healthcare Conference
Olema Oncology to Participate in Upcoming Investor Conferences
Eton Pharmaceuticals Expands Rare Disease Portfolio Through Agreement for U.S. Commercialization Rights to IMPAVIDO® (miltefosine)
Cadrenal Therapeutics to Participate in the Lytham Partners Spring 2026 Investor Conference on May 28, 2026
Ozari Health Launches Nationwide Telehealth Platform for Compounded Semaglutide and Tirzepatide Starting at $86 Per Month
RxSight, Inc. to Present at the Stifel 2026 Virtual Ophthalmology Forum
Annovis Announces Launch of Proposed Public Offering of Common Stock and Accompanying Warrants
Alps Group Inc Announces Receipt of Nasdaq Notification Regarding Minimum Bid Price Deficiency
Iridex Reports First Quarter 2026 Financial Results
Resmed Announces Participation in the 46th Annual William Blair Growth Stock Conference
Suja Life to Report First Quarter 2026 Financial Results on June 9, 2026
Artiva Biotherapeutics Announces Multiple AlloNK® Data Presentations at EULAR 2026 Congress, Including Late-Breaking Oral Presentation Highlighting Clinical Efficacy Comparable to Autologous CAR T-Cell Therapy in Rheumatologic Diseases
NurExone Receives Notice of Patent Grant in South Korea Covering ExoPTEN Technology

Share this page:

Sign up for:

Massachusetts Healthcare Journal

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.